On February 7, 2023 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, reported that management will present at the virtual SVB Securities Global Biopharma Conference (Press release, Harpoon Therapeutics, FEB 7, 2023, View Source [SID1234626935]). The corporate presentation will take place on Tuesday, February 14, 2023 at 1:40 p.m. ET (10:40 a.m. PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the company presentation will be available in the Investors section of the Harpoon Therapeutics website at www.harpoontx.com with an archived replay available following the event.